More Research Needed to Help Postmenopausal Females at Risk for Nonalcoholic Fatty Liver Disease
source: pixabay.com

More Research Needed to Help Postmenopausal Females at Risk for Nonalcoholic Fatty Liver Disease

by Natalie Homan from In The Cloud Copy A review article published in Endocrinology in August of this year highlights the fact that a female's risk of developing nonalcoholic fatty…

Continue Reading More Research Needed to Help Postmenopausal Females at Risk for Nonalcoholic Fatty Liver Disease
Can Rigosertib Change the Myelodysplastic Syndromes Treatment Landscape?
source: pixabay.com

Can Rigosertib Change the Myelodysplastic Syndromes Treatment Landscape?

By Lauren Taylor from In The Cloud Copy Onconova Therapeutics, Inc. is a biopharmaceutical company that works to develop new drugs to treat cancer, primarily focusing on myelodysplastic syndromes. Myelodysplastic…

Continue Reading Can Rigosertib Change the Myelodysplastic Syndromes Treatment Landscape?

Non-alcoholic Fatty Liver Disease: Study of Children Receiving Standard of Care Lifestyle Advice

by Danielle Bradshaw from In The Cloud Copy It’s possible for fat to end up stored inside of the liver due to either obesity, diabetes, certain medications, or high cholesterol.…

Continue Reading Non-alcoholic Fatty Liver Disease: Study of Children Receiving Standard of Care Lifestyle Advice